Krystal Biotech, Inc. (FRA:4KB)

Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,517	4,352	3,166	1,909	1,532	967
Market Cap Growth	46.48%	37.47%	65.87%	24.59%	58.47%	13.17%
Enterprise Value	5,782	3,689	2,632	1,536	1,220	735
Last Close Price	217.80	151.35	115.00	73.50	62.00	-
PE Ratio	38.44	50.54	320.10	-	-	-
PS Ratio	20.49	15.51	69.02	-	-	-
PB Ratio	6.72	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	6.72	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	46.18	37.81	-	-	-	-
P/OCF Ratio	43.39	36.51	-	-	-	-
EV/Sales Ratio	18.02	13.15	57.38	-	-	-
EV/EBITDA Ratio	41.73	36.14	-	-	-	-
EV/EBIT Ratio	42.47	37.01	-	-	-	-
EV/FCF Ratio	40.97	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	9.70%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.60%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.17%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.